Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00147901
Status:
COMPLETED
Last Update Posted:
2016-10-03
First Post:
2005-09-02
Brief Title:
Fludarabine Cyclophosphamide and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia B-CLL
Sponsor:
German CLL Study Group
Organization:
German CLL Study Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-11
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-02
First Submit QC Date:
September 2 2005
Study First Post Date:
2005-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-09-30
Last Update Post Date:
2016-10-03
Last Update Post Date Type:
ESTIMATED